Bo Gao
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Follistatin Alleviates Vascular Dysfunction by Reducing Oxidative Stress and Promoting Browning in Perivascular Adipose Tissue.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 27, 2026
LASP1 mediates ADAM17 upregulation in high glucose to promote fibrosis in diabetic kidneys.
Journal: Diabetologia
Published: July 26, 2025
miR-299a-5p is a mediator of fibrosis in diabetic kidney disease by regulating follistatin and cripto-1.
Journal: Communications biology
Published: May 07, 2025
Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells.
Journal: Biomolecules
Published: October 11, 2024
Inhibition of cell surface GRP78 and activated α2M interaction attenuates kidney fibrosis.
Journal: JCI insight
Published: June 25, 2024
Follistatin lowers blood pressure and improves vascular structure and function in essential and secondary hypertension.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: February 09, 2024
Both sexes develop DKD in the CD1 uninephrectomized streptozotocin mouse model.
Journal: Scientific reports
Published: December 06, 2022
Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease.
Journal: Frontiers in pharmacology
Published: November 14, 2022
A therapeutic target for CKD: activin A facilitates TGFβ1 profibrotic signaling.
Journal: Cellular & molecular biology letters
Published: September 02, 2022
Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease.
Journal: International journal of molecular sciences
Published: February 03, 2021
Last Updated: 09/26/2026